| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029949 |
| Receipt No. | R000034210 |
| Official scientific title of the study | Verification test on blood flow improvement effect by ingestion of black tea |
| Date of disclosure of the study information | 2017/11/13 |
| Last modified on | 2018/04/05 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Verification test on blood flow improvement effect by ingestion of black tea | |
| Title of the study (Brief title) | Verification test on blood flow improvement effect by ingestion of black tea | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of blood flow and body surface temperature effect of ingestion of black tea |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measuring blood flow and body surface temperature at before cooling stress and after 10, 20 and 30 minutes after cooling stress. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Capsules containing black tea (test capsules) | |
| Interventions/Control_2 | Capsules not containing black tea (placebo capsules) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy subject | |||
| Key exclusion criteria | 1) Subjects who are under medication or having a history of serious diseases for which medication was required.
2) Subjects who may be pregnant or possible pregnant. 3) Subjects who are lactating. 4) Subjects who are unsuitable for the entry judged by a doctor |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Haruko Takeyama |
| Organization | Waseda University (Graduate School) |
| Division name | Integrated Institute for Regulatory Science, Research Organization for Nano & Life Innovation |
| Address | 2-2, wakamatsu-cho, Shinjyuku, Tokyo |
| TEL | 03-5369-7326 |
| haruko-takeyama@waseda.jp | |
| Public contact | |
| Name of contact person | Naoko Takamizawa |
| Organization | Waseda University (Graduate School) |
| Division name | Integrated Institute for Regulatory Science, Research Organization for Nano & Life Innovation |
| Address | 2-2, wakamatsu-cho, Shinjyuku, Tokyo |
| TEL | 03-5369-7326 |
| Homepage URL | |
| takamizawa.n@aoni.waseda.jp | |
| Sponsor | |
| Institute | Waseda University (Graduate School) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Donated funds |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034210 |